Citizens Maintains Market Outperform on TELA Bio, Lowers Price Target to $3
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
Citizens analyst David Turkaly maintains TELA Bio (NASDAQ:TELA) with a Market Outperform and lowers the price target from $5 to $3.
Citizens analyst David Turkaly maintains TELA Bio (NASDAQ:TELA) with a Market Outperform and lowers the price target from $5 to $3.